ClinicalTrialsFinder

Histologically Confirmed Cervical Cancer, FIGO Stage IB3, IIA2, IIB, IIIC, and Assessed by the Researcher as Resectable Lesion Clinical Trials in Zhengzhou, Henan

1 recruitingZhengzhou, Henan, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Neoadjuvant Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer

Locally Advanced Cervical CancerFemale, Age ≥ 18 Years OldNo Previous Systemic Treatment for the Current Disease, Including Surgery, Antitumor Radiochemotherapy/Immunotherapy+6 more
The First Affiliated Hospital of Zhengzhou University29 enrolled1 locationNCT07104149